Download Files:
Products Details
Product Description
– Nizubaglustat is an inhibitor of Ceramide Glucosyltransferase or Glucosylceramide Synthase (GCS). Nizubaglustat also inhibits GBA2, involving in neuropathological lysosomal storage disorders[1][2].
Web ID
– HY-148786
Shipping
– Room temperature
Molecular Formula
– C24H32FNO5
References
– [1]Ghisaidoobe AT, et al. Identification and development of biphenyl substituted iminosugars as improved dual glucosylceramide synthase/neutral glucosylceramidase inhibitors. J Med Chem. 2014 Nov 13;57(21):9096-104.|[2]WHO Drug Information-World Health Organization (WHO).
CAS Number
– 1633666-49-5
Molecular Weight
– 433.51
SMILES
– FC1=C(C2=CC=CC=C2)C=CC(COCCCCCN3[C@H]([C@H]([C@@H]([C@H](C3)O)O)O)CO)=C1
Clinical Information
– No Development Reported
Research Area
– Neurological Disease
Solubility
– 10 mM in DMSO
Target
– Glucosylceramide Synthase (GCS)
Pathway
– Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
